Genzyme Corp. (Nasdaq: GENZ) announced that Synvisc, a market- leading viscosupplement used to treat pain due to osteoarthritis of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE